Risk Factors for Advanced Colonic Neoplasia and Hyperplastic Polyps in Asymptomatic Individuals

JAMA

Volumn 290, Issue 22, 2003, Pages 2959-2967

  Lieberman, David A ^a   Prindiville, Sheila ^b   Weiss, David G ^c   Willett, Walter ^d  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CALCIUM; CHOLESTEROL; FOLIC ACID; MULTIVITAMIN; NONSTEROID ANTIINFLAMMATORY AGENT; VITAMIN D;

ADULT; ADVANCED CANCER; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CHOLECYSTECTOMY; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; COLON ADENOMA; COLON CANCER; COLON POLYP; DIETARY FIBER; DIETARY INTAKE; DISEASE ASSOCIATION; DRUG USE; FAMILY HISTORY; FAT INTAKE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0345168925     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.22.2959     Document Type: Article

References (57)

1. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365-1371.
2. Hardcastle JD, Chamberlain J, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348: 1472-1477.
3. Kronborg, O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467-1471.
4. Jorgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing. Gut. 2002;50:29-32.
5. Niv Y, Lev-El M, Fraser G, Abuksis G, Tamir A. Protective effective of faecal occult blood test screening for colorectal cancer. Gut. 2002;50:33-37.
6. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992; 326:653-657.
7. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572-1575.
8. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk. Ann Intern Med. 2002;137:132-141.
9. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977-1981.
10. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603-1607.
11. Lieberman DA. Targeted colon cancer screening. Am J Gastroenterol. 1992;87:1085-1093.
12. Potter JD. Epidemiologic, environmental and lifestyle issues in colorectal cancer. In: Young GP, Rozen P, Levin B, eds. Prevention and Early Detection of Colorectal Cancer. Philadelphia, Pa: WB Saunders Co; 1996:23-43.
13. Vatn MH, Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer. 1982;49:819-825.
14. Williams AR, Balasooriya VA, Day DW. Polyps and cancer of the large bowel. Gut. 1982;23:835-842.
15. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594-642.
16. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Cheijfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med. 2000;343:162-168.
17. Willett WC. Nutritional Epidemiology. 2nd ed. New York, NY: Oxford University Press; 1998.
18. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol. 1992;135:1114-1126.
19. Kannel WB, Sorile P. Some health benefits of physical activity. Arch Intern Med. 1979;139:857-861.
20. Chasan-Taber S, Rimm EB, Stampfer MJ, et al. Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals. Epidemiology. 1996;7:81-86.
21. Ainsworth BE, Haskell WL, Leon AS, et al. Compendium of physical activities. Med Sci Sports Exerc. 1993;25:71-80.
22. Hosmer DW, Lemeshow S. New York, NY: Applied Logistic Regression. John Wiley & Sons; 1989.
23. Lee I-M, Paffenbarger RS Jr. Quetelet's index and risk of colon cancer in college alumni. J Natl Cancer Inst. 1992;84:1326-1331.
24. Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity and risk for colon cancer and adenoma in men. Ann Intern Med. 1995;122:327-334.
25. Tornberg SA, Holm L-E, Carstensen JM, Eklund GA. Risks of cancer of the colon and rectum in relation to serum cholesterol and beta-lipoprotein. N Engl J Med. 1986;315:1629-1633.
26. Mannes GA, Maier A, Thieme C, Wiebecke B, Paumgartner G. Relation between the frequency of colorectal adenoma and the serum cholesterol level. N Engl J Med. 1986;315:1634-1638.
27. McFarlane MJ, Welch KE. Gallstones, cholecystectomy and colorectal cancer. Am J Gastroenterol. 1993;88:1994-1999
28. Giovannucci E, Colditz GA, Stampfer MJ. A meta-analysis of cholecystectomy and risk of colorectal cancer. Gastroenterology. 1993;105:130-141.
29. Lagergren J, Ye W, Ekbom A. Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis? Gastroenterology. 2001;121:542-547.
30. Schatzkin A, Lanza E, Corle D, et al, and the Polyp Prevention Trial Study Group. Lack of effect of a low-fat, high-fiber diet on the recurrent of colorectal adenomas. N Engl J Med. 2000;342:1149-1155.
31. Alberts DS, Martinez ME, Roe DJ, et al. Lack of effect of high-fiber cereal supplement on the recurrence of colorectal adenomas. N Engl J Med. 2000; 342:1156-1162.
32. Shabahang M, Buras RR, Davoodi F, et al. Growth inhibition of HT-29 human colon cancer cells buy analogues of 1,25-dihyroxyvitamin D3. Cancer Res. 1994; 54:4057-4064.
33. Garland C, Shekelle RB, Barrett-Connor E, et al. Dietary vitamin D and calcium and risk of colorectal cancer. Lancet. 1985;1:307-309.
34. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED. Serum 25-hydroxy vitamin D and colon cancer. Lancet. 1989;2:1176-1178.
35. Martinez ME, Willett WC. Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev. 1998;7:163-168.
36. Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med. 1999;340:101-107.
37. Bonithon-Kopp C, Dronborg O, et al. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence. Lancet. 2000;356:1300-1306.
38. Cannon-Albright LA, Skolnick MH, Bishop T, Lee RG, Burt RW. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med. 1988;319:533-537.
39. Fuchs CS, Biovannucci EL, Colditz GA, et al. A prospective study of family history and risk of colorectal cancer. N Engl J Med. 1994;331:1669-1674.
40. St John DJ, McDermott FT, Hopper JL, et al. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med. 1993;118:785-790.
41. Pariente A, Milan C, Lafon J, Faivre J. Colonoscopic screening in first-degree relatives of patients with sporadic colorectal cancer: a case-control study. Gastroenterology. 1998;115:7-12.
42. Giovannucci E, Rimm EB, Stampfer MJ, et al: A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in US men. J Natl Cancer Inst. 1994;86:183-191.
43. Sandler RS, Lyles CM, McAuliffe C, Woosley JT, Kupper LL. Cigarette smoking, alcohol and the risk of colorectal adenomas. Gastroenterology. 1993;104: 1445-1451.
44. Kikendall JW, Bowen PE, Burgess MB, Magnetti C, Woodward J, Langenberg P. Cigarettes and alcohol as independent risk factors for colonic adenomas. Gastroenterology. 1989;97:660-664.
45. Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC. Alcohol, low methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst. 1995;87:265-273.
46. Bardou M, Montembault S, Giraud V, et al. Excessive alcohol consumption favours high risk polyp or colorectal cancer occurrence among patients with adenomas: a case control study. Gut. 2002;50:38-42.
47. Thun MJ, Manboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1991;325:1593-1596.
48. Rosenberg L, Pamer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst. 1991;83:355-358.
49. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med. 1994;121:241-246.
50. Giovannucci E, Egan KM, Hjunter DJ, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995;333:609-614.
51. Sandler RS, Galanko JC, Murray SC, Helm JF, Woosely JT. Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas. Gastroenterology. 1998;114:441-447.
52. Steinbach G, Lynch PM, Phillips RK, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor in familial adenomatous polyposis. N Engl J Med. 2000;342: 1946-1952.
53. Greenberg ER, Baron JA, Freeman DH Jr, Mandel JS, Haile R. Reduced risk of large-bowel adenomas among aspirin users. J Natl Cancer Inst. 1993;85:912-916.
54. Sturmer T, Glynn RJ, Lee IM, Manson JE, Buring JE, Hennekens CH. Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study. Ann Intern Med. 1998;128:713-720.
55. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med. 1999;340:1888-1899.
56. Imperiale TF, Wagner DR, Lin CY, Larkin GR, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343:169-174.
57. Ulvik A, Evensen ET, Lien EA, et al. Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps or the colorectum. Am J Med Genet. 2001;101:246-254.